According to @business, BillionToOne, a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering during a US government shutdown that complicated the listing process, confirming the deal closed despite administrative constraints from the shutdown source: @business. The source characterizes the transaction as upsized and specifies the total proceeds of $273.1 million, while not providing pricing, valuation, ticker, allocation, or first-day trading performance details source: @business. The source does not reference any direct cryptocurrency market impact or digital asset linkage related to this IPO source: @business.